Results for “Xolair”

News, research, episodes and posts (2)

• Trial recruiting · ClinicalTrials.gov · Jun 8

  Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels (opens in a new tab)

  Phase 2 · Ages 1 to 55 · Sites in 1 US state

  In this project, the investigators would like to learn if 24 weeks (about 5 and a half months) of omalizumab injections, given every 2 weeks, will be safe and effective for food allergic people who have a total immunoglobulin E (IgE) above the current FDA…

  ResearchTreatmentsTesting and diagnosis
• Trial recruiting · ClinicalTrials.gov · Feb 5

  Omalizumab Weight-Based Dosing Efficacy Trial (opens in a new tab)

  Phase 2 · Ages 1 to 55 · Sites in 3 US states

  This research is being conducted to assess the safety and effectiveness of increased dosing of Omalizumab for food allergies. Conditions: Allergies, Food Allergy. Tested: 5mg/kg omalizumab injection, 15mg/kg omalizumab injection.

  ResearchTreatments